KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) EBITDA (2016 - 2026)

Exelixis has reported EBITDA over the past 17 years, most recently at $235.2 million for Q1 2026.

  • Quarterly results put EBITDA at $235.2 million for Q1 2026, up 44.12% from a year ago — trailing twelve months through Jan 2026 was $872.2 million (up 44.26% YoY), and the annual figure for FY2026 was $872.2 million, up 44.26%.
  • EBITDA for Q1 2026 was $235.2 million at Exelixis, down from $236.5 million in the prior quarter.
  • Over the last five years, EBITDA for EXEL hit a ceiling of $275.9 million in Q2 2024 and a floor of -$48.1 million in Q4 2022.
  • Median EBITDA over the past 5 years was $83.5 million (2022), compared with a mean of $115.6 million.
  • Peak annual rise in EBITDA hit 1906.88% in 2022, while the deepest fall reached 140.74% in 2022.
  • Exelixis' EBITDA stood at -$48.1 million in 2022, then skyrocketed by 270.12% to $81.8 million in 2023, then soared by 66.38% to $136.1 million in 2024, then skyrocketed by 73.83% to $236.5 million in 2025, then dropped by 0.56% to $235.2 million in 2026.
  • The last three reported values for EBITDA were $235.2 million (Q1 2026), $236.5 million (Q4 2025), and $213.6 million (Q3 2025) per Business Quant data.